Helicobacter

Article	Citations
The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults	45
Effects of non‐viableLactobacillus reutericombining with 14‐day standard triple therapy onHelicobacter pylorieradication: A randomized double‐blind placebo‐controlled trial	37
Optimization of vonoprazan‐amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study	37
Helicobacter pylori induced reactive oxygen Species: A new and developing platform for detection	31
PPI‐amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta‐analysis	30
Transmission routes and patterns of helicobacter pylori	30
CRISPR‐based detection of Helicobacter pylori in stool samples	28
An overview of traditional Chinese medicine therapy for Helicobacter pylori–related gastritis	28
Helicobacter pylori induces gastric cancer via down‐regulating miR‐375 to inhibit dendritic cell maturation	26
Effects of enhanced education for patients with the Helicobacter pylori infection: A systematic review and meta‐analysis	25
The efficacy of Helicobacter pylori eradication in diabetics and its effect on glycemic control: A systematic review and meta‐analysis	25
Impact of smoking on the eradication of Helicobacter pylori	24
Eradication rates of Helicobacter pylori in treatment‐naive patients following 14‐day vonoprazan‐amoxicillin dual therapy: A multicenter randomized controlled trial in China	23
Helicobacter pylori infection and the progression of atherosclerosis: A systematic review and meta‑analysis	23
Effects of sodium butyrate supplementation on inflammation, gut microbiota, and short‐chain fatty acids in Helicobacter pylori‐infected mice	23
Association between bacteria other than Helicobacter pylori and the risk of gastric cancer	22
The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota—a double‐blind, placebo‐controlled, randomiz	22
Whole family—based Helicobacter pylori eradication is a superior strategy to single‐infected patient treatment approach: A systematic review and meta‐analysis	21
Influence of Helicobacter pylori infection on PD‐1/PD‐L1 blockade therapy needs more attention	21
Efficacy of eradication therapy in Helicobacter pylori‐negative gastric mucosa‐associated lymphoid tissue lymphoma: A meta‐analysis	21
Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice	21
Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota	21
Quadruple therapy with vonoprazan 20 mg daily as a first‐line treatment for Helicobacter pylori infection: A single‐center, open‐label, noninferiority, randomized controlled trial	20
Impact of body size on first‐line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy	20
Need for standardization and harmonization of Helicobacter pylori antimicrobial susceptibility testing	19

Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial	19
Advantage of 16S rRNA amplicon sequencing in Helicobacter pylori diagnosis	19
Helicobacter pylori infection is associated with the co‐occurrence of bacteria in the oral cavity and the gastric mucosa	19
Eradication rate and safety of a “simplified rescue therapy”: 14‐day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in	19
Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions	18
Helicobacter pylori adhesins: HpaA a potential antigen in experimental vaccines for H. pylori	18
The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing	17
Transmission ofHelicobacter pyloribetween a human and two dogs: A case report	17
Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections—Exploratory study	17
Prevalence and risk factors of Helicobacter pylori infection in Wuwei, a high‐risk area for gastric cancer in northwest China: An all‐ages population‐based cross‐sectional study	16
Helicobacter pylori infection and risk of cardiovascular disease	16
Efficacy of tegoprazan‐based bismuth quadruple therapy compared with bismuth quadruple therapy for Helicobacter pylori infection: A randomized, double‐blind, active‐controlled study	16
Cardia and non‐cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta‐analysis, and estimation of population attributable fraction	15
Association between Helicobacter pylori infection and growth outcomes in children: A meta‐analysis	15
Helicobacter pylori and the intestinal microbiome among healthy school‐age children	15
Diagnosis and treatment of Helicobacter pylori infection by physicians in China: A nationwide cross‐sectional study	15
Extracellular vesicles from helicobacter pylori‐infected cells and helicobacter pylori outer membrane vesicles in atherosclerosis	15
Perspectives from recent advances of Helicobacter pylori vaccines research	15
Application of WeChat platform in the management of patients infected with Helicobacter pylori	15
Eradication of Helicobacter pylori infection decreases risk for dyslipidemia: A cohort study	15
Gastric organoids: Advancing the study of H. pylori pathogenesis and inflammation	15
The recurrence rate ofHelicobacter pyloriin recent 10 years: A systematic review and meta‐analysis	15
Pepsinogen II in gastritis and Helicobacter pylori infection	15
Immune evaluation of aSaccharomyces cerevisiae‐based oral vaccine againstHelicobacter pyloriin mice	15
Prevalence, clinical features, and esophagogastroduodenoscopy (EGD) findings of non‐Helicobacter pylori Helicobacter infection: A study of 50 cases at a single facility in Japan	15
Association betweenHelicobacter pyloriantibodies determined by multiplex serology and gastric cancer risk: A meta‐analysis	14
Long term impact of vonoprazan‐based Helicobacter pylori treatment on gut microbiota and its relation to post‐treatment body weight changes	14
Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost‐effectiveness analysis	14
Dynamic changes in antibiotic resistance genes and gut microbiota afterHelicobacter pylorieradication therapies	14
TikTok and Bilibili as sources of information on Helicobacter pylori in China: A content and quality analysis	14
10‐Day and 14‐day high‐dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis	14
Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐lineHelicobacter pylorieradication regimen	13
Rabeprazole plus amoxicillin dual therapy is equally effective to bismuth‐containing quadruple therapy for Helicobacter pylori eradication in central China: A single‐center, prospective, open‐l	13
Helicobacter pylori infection and risk of multiple sclerosis: An updated meta‐analysis	13
Both family‐based Helicobacter pylori infection control and management strategy and screen‐and‐treat strategy are cost‐effective for gastric cancer prevention	12
Long‐term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children	12
Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost‐effectiveness analysis	12
Adherence to Maastricht V/Florence consensus report for the management ofHelicobacter pyloriinfection among primary care physicians and medical students in Croatia: A cross‐sectional study	12
Helicobacter pylori knowledge and perception among multi‐ethnic Asians	12
Long noncoding RNA NEAT1 promotes tumorigenesis in H. pylori gastric cancer by sponging miR‐30a to regulate COX‐2/BCL9 pathway	12
Investigation of endoscopic findings in nine cases of Helicobacter suis‐infected gastritis complicated by gastric mucosa‐associated lymphoid tissue lymphoma	12
Application of molecular techniques inHelicobacter pyloridetection: limitations and improvements	11
Unraveling antimicrobial resistance in Helicobacter pylori: Global resistome meets global phylogeny	11
New regimens as first‐line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial	11
Prevalence estimates of Helicobacter species infection in pancreatic and biliary tract cancers	11
Efficacy and safety of bismuth‐based quadruple therapy forHelicobacterpylorieradication in children	11
Helicobacter pylori and cardiovascular risk: Only a dead Helicobacter is a good Helicobacter?	11
Effect of enhanced patient instructions onHelicobacter pylorieradication: A systematic review and meta‐analysis of randomized controlled trials	11
Declining trends of prevalence ofHelicobacter pyloriinfection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis	11
Helicobacter pylori‐positive chronic atrophic gastritis and cellular senescence	11

Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines	10
YouTube as a source of information on Helicobacter pylori: Content and quality analysis	10
Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea	10
“True” Helicobacter pylori infection and non‐cardia gastric cancer: A pooled analysis within the Stomach Cancer Pooling (StoP) Project	10
Efficacy of bismuth added to standard triple therapy as the first‐line eradication regimen for Helicobacter pylori infection	10
Does technology‐enhanced communication improve Helicobacter pylori eradication outcomes?—A meta‐analysis	10
Doxycycline and minocycline inHelicobacter pyloritreatment: A systematic review and meta‐analysis	10
Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double‐blind, placebo‐controlled trial	10
Tetracycline‐levofloxacin versus amoxicillin‐levofloxacin quadruple therapies in the second‐line treatment of Helicobacter pylori infection	10
Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study	9
Integrative proteomic and metabolomic analyses reveal the mechanism by which bismuth enables Helicobacter pylori eradication	9
Comparison of clinical outcomes and FOXP3, IL‐17A responses in Helicobacter pylori infection in children versus adults	9
Gastrointestinal adverse reactions reduce the success rate of Helicobacter pylori eradication therapy: A multicenter prospective cohort study	9
Cholesterol glucosylation–based survival strategy in Helicobacter pylori	9
Heat‐killed Helicobacter pylori upregulates NKG2D ligands expression on gastric adenocarcinoma cells via Toll‐like receptor 4	9
AI‐2 represses CagA expression and bacterial adhesion, attenuating the Helicobacter pylori‐induced inflammatory response of gastric epithelial cells	9
Helicobacter pylori treatment knowledge, access and barriers: A cross‐sectional study	9
Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy	9
Influences ofHelicobacter pyloriinfection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer development	9
Lessons learned from upper gastrointestinal endoscopy in asymptomatic Chinese	8
Antibiotic resistance, heteroresistance, and eradication success ofHelicobacter pyloriinfection in children	8
Dietary multivalent anti‐Helicobacter pylori immunoglobulin Y significantly increase the H. pylori eradication and improve the clinical symptoms in patients	8
Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta‐analysis and critical analysis	8
Clinical evaluation of a novel molecular diagnosis kit for detecting Helicobacter pylori and clarithromycin‐resistant using intragastric fluid	8
Clinicopathological features of nodular gastritis in three classes of age	8
Exploration of the molecular mechanisms underlying the antibiotic resistance of Helicobacter pylori: A whole‐genome sequencing‐based study in Southern China	8
Saccharomyces boulardii CNCM I‐745 supplementation modifies the fecal resistome during Helicobacter pylori eradication therapy	8
Age of eradication and failure rates of clarithromycin‐containing triple therapy forHelicobacter pylori: A 15‐year population‐based study	8
Consistency of Helicobacter pylori eradication rates of first‐line concomitant and sequential therapies in Korea: A nationwide multicenter retrospective study for the last 10 years	8
Research Trends on Clinical Helicobacter pylori Eradication: A Bibliometric Analysis from 1983 to 2020	8
Vonoprazan and amoxicillin dual therapy as the first‐line treatment of Helicobacter pylori infection: A systematic review and meta‐analysis	8
Optimized dual therapy for treatment‐naive patients of Helicobacter pylori infection: A large‐scale prospective, multicenter, open‐label, randomized controlled study	7
Pilot studies of vonoprazan‐containing Helicobacter pylori eradication therapy suggest Thailand may be more similar to the US than Japan	7
Efficacy of bismuth for antibiotic‐resistant Helicobacter pylori strains eradication: A systematic review and meta‐analysis	7
An American lineage of Helicobacter pylori prophages found in Colombia	7
Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta‐analysis	7
Activation of Aquaporin 5 by carcinogenic Helicobacter pylori infection promotes epithelial‐mesenchymal transition via the MEK/ERK pathway	7
Adaptation of an in‐house PCR for the detection of Helicobacter pylori and the mutations associated with macrolide resistance into ready‐to‐use PCR microwell strips	7
Helicobacter pylori regulated microRNA map of human gastric cells	7
Correlation between the intensity of Helicobacter pylori colonization and severity of gastritis: Results of a prospective study	7
CagA+Helicobacter pylori infection and N‐nitrosodimethylamine administration induce cholangiocarcinoma development in hamsters	7
A comprehensive evaluation of an animal model for Helicobacter pylori‐associated stomach cancer: Fact and controversy	7
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia	7
Persistent advanced periductal fibrosis is associated with cagA‐positive Helicobacter pylori infection in post‐praziquantel treatment of opisthorchiasis	7
Increased risk of short‐term depressive disorder after Helicobacterpylori eradication: A population‐based nested cohort study	7
Reactive oxygen species and gastric carcinogenesis: The complex interaction between Helicobacter pylori and host	6
Gastric microbiota in gastric cancer and precancerous stages: Mechanisms of carcinogenesis and clinical value	6
Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan‐amoxicillin dual therapy for Helicobacter pylori eradication	6
Evaluation of guidelines for diagnosis and treatment of Helicobacter pylori infection	6
Glycosyltransferase Jhp0106 (PseE) contributes to flagellin maturation in Helicobacterpylori	6
A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy o	6
Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow‐up of 51 months	6
Favorable outcomes of rescue second‐ or third‐line culture‐based Helicobacter pylori eradication treatment in areas of high antimicrobial resistance	6
Metabolic alterations in patients with Helicobacter pylori‐related gastritis: The H. pylori‐gut microbiota‐metabolism axis in progression of the chronic inflammation in the gastric mucos	6
Helicobacter pylori infection reduces the efficacy of cancer immunotherapy: A systematic review and meta‐analysis	6
Quantitative PCR of string‐test collected gastric material: A feasible approach to detect Helicobacter pylori and its resistance against clarithromycin and levofloxacin for susceptib	6
Efficacy and safety of vonoprazan‐based dual therapy and esomeprazole‐based dual therapy in eradicating primary Helicobacter pylori infection: A propensity score matching analysis	6
Effect ofHelicobacter pylorion immunotherapy is gaining more attention	6
Upregulation of oncogene Activin A receptor type I by Helicobacter pylori infection promotes gastric intestinal metaplasia via regulating CDX2	6
Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori	6
Effect of Helicobacter pylori infection and its eradication on the expression of tight junction proteins in the gastric epithelium in relation to gastric carcinogenesis	6
Atrophic gastritis in Helicobacter pylori‐infected children	6
Long‐term improvement in constipation‐related symptoms after Helicobacter pylori eradication therapy	6
The role of toll‐like receptors in immune tolerance induced by Helicobacter pylori infection	6
Dialogue between gastrointestinal tract and skin: New insights into the Helicobacter pylori and atopic dermatitis	5
Antibiotic resistance patterns of Helicobacter pylori in North Israel – A six‐year study	5
Interactions between Helicobacter pylori infection and host metabolic homeostasis: A comprehensive review	5
Effect of Helicobacter pylori eradication therapy on clinical and laboratory biomarkers associated with gastric damage in healthy school‐aged children: A randomized non‐blinded trial	5
Reinforced medication adherence improvesHelicobacter pylorieradication rate in developing countries: A systematic review and meta‐analysis of randomized controlled trials	5
Individualized diagnosis and eradication therapy for Helicobacter pylori infection based on gene detection of clarithromycin resistance in stool specimens: A systematic review and meta‐analysis	5
Antibiotic resistance and heteroresistance in Helicobacter pylori isolates from symptomatic Vietnamese children: A prospective multicenter study	5
New insight on the role of Helicobacter pylori cagA in the expression of cell surface antigens with important biological functions in gastric carcinogenesis	5
Virulence assessment of enterohepaticHelicobacterspecies carried by dogs using the wax moth larvaeGalleria mellonellaas infection model	5
Helicobacterspecies binding to the human gastric mucosa	5
Helicobacter pylori virulence genotypes in Bogotá River and wastewater treatment plants in Colombia	5
Mistakes in the diagnosis and treatment of Helicobacter pylori infection in daily clinical practice	5
Prevalence of Helicobacter pylori infection among resettled refugees presenting to a family medicine clinic in the United States	5
Classification system forHelicobacter pyloritherapies: Compared and contrasted to traditional infectious disease therapy	5
Discussion on the common controversies of Helicobacter pylori infection	5
Low compliance to post‐screening recommendations in a family‐based Helicobacter pylori screening and treatment program: A prospective cohort study	5

Effect of Helicobacter pylori eradication on hyperplastic gastric polyps: A systematic review and meta‐analysis	5
Vonoprazan‐amoxicillin dual therapy versus bismuth‐containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis	5
Reverse hybrid therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis	4
Bibliometric analysis of Helicobacter pylori resistance—from 2002 to 2022	4
Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin	4
Gastric foveolar elongation causes invisibility of regular arrangement of collecting venules in chronic active and inactive gastritis	4
Risk of map‐like redness development after eradication therapy for Helicobacter pylori infection	4
SHP2/SPI1axis promotes glycolysis and the inflammatory response of macrophages in Helicobacter pylori‐induced pediatric gastritis	4
Information quality of videos related to Helicobacter pylori infection on TikTok: Cross‐sectional study	4
Evaluation of the effects of a proton pump inhibitor on Helicobacter pylori stool antigen testing	4
Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021	4
Designing strategies for eradication of Helicobacter pylori based on prevalence patterns of infection and antibiotic resistance in a low‐income, medically underserved community in the United St	4
Acute gastric mucosal lesions caused by acute infection of non‐HelicobacterpyloriHelicobacter: a case report	4
Comparative analysis of large language models in medical counseling: A focus on Helicobacter pylori infection	4
Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants—A review	4
Meta‐analysis of Helicobacter pylori eradication therapy using vonoprazan as an acid suppressor compared with bismuth quadruple therapy	4
Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review	3
Urolithin B alleviates Helicobacter pylori‐induced inflammation and oxidative stress in mice	3
DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection	3
Considerations in comparing intestinal‐ and diffuse‐type gastric adenocarcinomas	3
Campylobacter concisus gastritis masquerading as Helicobacter pylori on gastric biopsy	3
GM‐CSF is key in the efficacy of vaccine‐induced reduction of Helicobacter pylori infection	3
Research trends on vonoprazan‐based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 2023	3
Helicobacter bilis infection induces oxidative stress in and enhances the proliferation of human cholangiocytes	3
A standardized protocol improves testing rates for Helicobacter Pylori among inpatients with peptic ulcer disease	3
Establishment of a reference panel of Helicobacter pylori strains for antimicrobial susceptibility testing	3
Regulatory B cells (Bregs) in Helicobacter pylori chronic infection	3
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for Helicobacter pylori eradication: A randomized controlled trial	3
Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development	3
Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta‐analysis of RCTs	3
Disruption of the gastric epithelial barrier in Correa's cascade: Clinical evidence via confocal endomicroscopy	3
Gastric mucosal swab as an alternative to biopsy for Helicobacter pylori detection	3
Adherence to international guidelines for the management ofHelicobacter pyloriinfection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Di	2
Critical appraisal of international guidelines for the management of Helicobacter pylori infection in case of dyspepsia	2
Microbiome and function alterations in the gastric mucosa of asymptomatic patients with Helicobacter pylori infection	2
Transcriptomic remodeling of gastric cells by Helicobacter pylori outer membrane vesicles	2
Time trend prevalence of helicobacter pylori infection and endoscopic findings in symptomatic children in Portugal: A retrospective study based on three time points in 2009, 2014, and 2019	2
Gastric Helicobacter pylori infection does not contribute to extraoral halitosis and its eradication cannot achieve substantial reduction of halitosis	2
Exploring the capacities of ChatGPT: A comprehensive evaluation of its accuracy and repeatability in addressing helicobacter pylori‐related queries	2
The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response	2
Vonoprazan‐based therapies versus PPI‐based therapies in patients with H. pylori infection: Systematic review and meta‐analyses of randomized controlled trials	2
Antimicrobial‐resistant Helicobacter pylori in Japan: Report of nationwide surveillance for 2018–2020	2
Helicobacter pylori infection and inflammasomes	2
Incidence of gastrointestinal malignancies increases in persons received eradication therapy for Helicobacter pylori: A cohort study	2
Efficacy of genotypic susceptibility‐guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta‐analysis	2
Association of Helicobacter pylori with migraine headaches and the effects of this infection and its eradication on the migraine characteristics in adults: A comprehensive systematic review and	2
H. pylori predictors and outcomes among adults undergoing upper endoscopy at a Jamaican teaching hospital: A cross‐sectional study	2
Impact of body size on efficacy of high‐dose dual therapy for Helicobacter pylori eradication	2
A “new” option in Helicobacter pylori eradication: High‐dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting	2
Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter study from 2016 to 2023	2
Helicobacter pylori infection found during upper endoscopy performed for the diagnosis of celiac, inflammatory bowel diseases, and eosinophilic esophagitis: A multicenter pediatric European stu	2
Association between genetic polymorphisms of NOD1, Interleukin‐1B, and cagA strain with low‐grade duodenal eosinophilia in Helicobacter pylori‐related dyspepsia	2
Risk of hospitalization for upper gastrointestinal bleeding in Helicobacter pylori eradicated patients newly started on warfarin or direct oral anticoagulants: A population‐based cohort study	2
Comparison between the GastroPanel test and the serum pepsinogen assay interpreted with the ABC method—A prospective study	2
The first 5 years of Helicobacter pylori research—With an emphasis on the United Kingdom	2
Low‐dose or high‐dose amoxicillin in vonoprazan‐based dual therapy for Helicobacter pylori eradication? A systematic review and meta‐analysis	2
Antibiotic resistance patterns and therapeutic outcomes of pediatric Helicobacter pylori infection in a high‐migrant Singaporean cohort	2
UreBimmunodominant epitope‐specificCD8+T‐cell responses were beneficial in reducing gastric symptoms inHelicobacter pylori‐infected individuals	2
Machine learning models in predicting failure ofHelicobacter pyloritreatment: A two country validation study	2